Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLEX-D ET: BoNT Injection Patterns for Essential Tremor
NCT02909907Completed
- Sponsor
- Cleveland Clinic
- Start
- Aug 2016
- Primary completion
- Feb 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of botulinum toxin type A in essential tremor (ET) (2 arms), sponsored by Cleveland Clinic. Primary endpoint: Patient Global Impression of Improvement Scale at 6 weeks. Started Aug 2016; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
essential tremor (ET)
Beyond the preview
Go deeper on NCT02909907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02909907.